Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019

Detalhes bibliográficos
Autor(a) principal: Nascimento,Maria Isabel do
Data de Publicação: 2022
Outros Autores: Przibilski,Ana Luísa Ferreira, Coelho,Carolina Sampaio Gomes, Leite,Katyslaine Frossard de Amorim, Makenze,Mariana, Jesus,Stella Bayer de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista de Saúde Pública
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102022000100254
Resumo: ABSTRACT OBJECTIVE Estimate rates and describe mortality trends attributed to sickle cell disease in children and adolescents in Brazil from 2000 to 2019. METHODS This is an ecological study of the time-trend of mortality rates that used the autoregressive method, proposed by Prais-Winsten, to evaluate trends in the estimated rates of sickle cell disease deaths in children and adolescents in Brazil. Deaths with code D57 were obtained from the Mortality Information System, considering age groups (0–4, 5–9, 10–14, 15–19 years) and were used to estimate age-specific and standardized rates by gender and age. RESULTS From 2000 to 2019, Brazil had 2,422 deaths from sickle cell disease in people under 20 years of age, with higher frequency in the Northeast (40.46%), followed by the Southeast (39.02%), Midwest (9.58%), North (7.84%), and South (3.10%). The main victims were people of Black skin/race (78.73%). In Brazil, the global standardized average rate was 0.20/100,000 people-year, with an elevation trend (annual percentage change – APC = 5.44%; confidence interval – 95%CI: 2.57–8.39). The pattern was repeated in males (APC = 4.38%; 95%CI: 2.17–6.64) and females (APC = 6.96%; 95%CI: 3.05–11.01). Elaborating age-specific rates showed that the range up to four years experienced the highest rates, without distinction by region. The age group of 15 and 19 years was the second most affected in Brazil and in the Northeast, Southeast, and Midwest regions. CONCLUSION Deaths due to sickle cell disorders showed an elevation trend in children and adolescents. Considering that the magnitude of deaths was more evident in the first years (0–4) and late adolescence (15–19), the study suggests that age-specific approaches may impact the control of fatal outcomes caused by sickle cell disease in Brazil.
id USP-23_9731f30ec88e75575b3c17bd4aa61843
oai_identifier_str oai:scielo:S0034-89102022000100254
network_acronym_str USP-23
network_name_str Revista de Saúde Pública
repository_id_str
spelling Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019ChildAdolescentAnemia, Sickle Cell, epidemiologyMortality, trendsTime Series StudiesABSTRACT OBJECTIVE Estimate rates and describe mortality trends attributed to sickle cell disease in children and adolescents in Brazil from 2000 to 2019. METHODS This is an ecological study of the time-trend of mortality rates that used the autoregressive method, proposed by Prais-Winsten, to evaluate trends in the estimated rates of sickle cell disease deaths in children and adolescents in Brazil. Deaths with code D57 were obtained from the Mortality Information System, considering age groups (0–4, 5–9, 10–14, 15–19 years) and were used to estimate age-specific and standardized rates by gender and age. RESULTS From 2000 to 2019, Brazil had 2,422 deaths from sickle cell disease in people under 20 years of age, with higher frequency in the Northeast (40.46%), followed by the Southeast (39.02%), Midwest (9.58%), North (7.84%), and South (3.10%). The main victims were people of Black skin/race (78.73%). In Brazil, the global standardized average rate was 0.20/100,000 people-year, with an elevation trend (annual percentage change – APC = 5.44%; confidence interval – 95%CI: 2.57–8.39). The pattern was repeated in males (APC = 4.38%; 95%CI: 2.17–6.64) and females (APC = 6.96%; 95%CI: 3.05–11.01). Elaborating age-specific rates showed that the range up to four years experienced the highest rates, without distinction by region. The age group of 15 and 19 years was the second most affected in Brazil and in the Northeast, Southeast, and Midwest regions. CONCLUSION Deaths due to sickle cell disorders showed an elevation trend in children and adolescents. Considering that the magnitude of deaths was more evident in the first years (0–4) and late adolescence (15–19), the study suggests that age-specific approaches may impact the control of fatal outcomes caused by sickle cell disease in Brazil.Faculdade de Saúde Pública da Universidade de São Paulo2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102022000100254Revista de Saúde Pública v.56 2022reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USP10.11606/s1518-8787.2022056003681info:eu-repo/semantics/openAccessNascimento,Maria Isabel doPrzibilski,Ana Luísa FerreiraCoelho,Carolina Sampaio GomesLeite,Katyslaine Frossard de AmorimMakenze,MarianaJesus,Stella Bayer deeng2022-06-29T00:00:00Zoai:scielo:S0034-89102022000100254Revistahttp://www.scielo.br/scielo.php?script=sci_serial&pid=0034-8910&lng=pt&nrm=isoONGhttps://old.scielo.br/oai/scielo-oai.phprevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2022-06-29T00:00Revista de Saúde Pública - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019
title Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019
spellingShingle Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019
Nascimento,Maria Isabel do
Child
Adolescent
Anemia, Sickle Cell, epidemiology
Mortality, trends
Time Series Studies
title_short Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019
title_full Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019
title_fullStr Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019
title_full_unstemmed Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019
title_sort Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000–2019
author Nascimento,Maria Isabel do
author_facet Nascimento,Maria Isabel do
Przibilski,Ana Luísa Ferreira
Coelho,Carolina Sampaio Gomes
Leite,Katyslaine Frossard de Amorim
Makenze,Mariana
Jesus,Stella Bayer de
author_role author
author2 Przibilski,Ana Luísa Ferreira
Coelho,Carolina Sampaio Gomes
Leite,Katyslaine Frossard de Amorim
Makenze,Mariana
Jesus,Stella Bayer de
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Nascimento,Maria Isabel do
Przibilski,Ana Luísa Ferreira
Coelho,Carolina Sampaio Gomes
Leite,Katyslaine Frossard de Amorim
Makenze,Mariana
Jesus,Stella Bayer de
dc.subject.por.fl_str_mv Child
Adolescent
Anemia, Sickle Cell, epidemiology
Mortality, trends
Time Series Studies
topic Child
Adolescent
Anemia, Sickle Cell, epidemiology
Mortality, trends
Time Series Studies
description ABSTRACT OBJECTIVE Estimate rates and describe mortality trends attributed to sickle cell disease in children and adolescents in Brazil from 2000 to 2019. METHODS This is an ecological study of the time-trend of mortality rates that used the autoregressive method, proposed by Prais-Winsten, to evaluate trends in the estimated rates of sickle cell disease deaths in children and adolescents in Brazil. Deaths with code D57 were obtained from the Mortality Information System, considering age groups (0–4, 5–9, 10–14, 15–19 years) and were used to estimate age-specific and standardized rates by gender and age. RESULTS From 2000 to 2019, Brazil had 2,422 deaths from sickle cell disease in people under 20 years of age, with higher frequency in the Northeast (40.46%), followed by the Southeast (39.02%), Midwest (9.58%), North (7.84%), and South (3.10%). The main victims were people of Black skin/race (78.73%). In Brazil, the global standardized average rate was 0.20/100,000 people-year, with an elevation trend (annual percentage change – APC = 5.44%; confidence interval – 95%CI: 2.57–8.39). The pattern was repeated in males (APC = 4.38%; 95%CI: 2.17–6.64) and females (APC = 6.96%; 95%CI: 3.05–11.01). Elaborating age-specific rates showed that the range up to four years experienced the highest rates, without distinction by region. The age group of 15 and 19 years was the second most affected in Brazil and in the Northeast, Southeast, and Midwest regions. CONCLUSION Deaths due to sickle cell disorders showed an elevation trend in children and adolescents. Considering that the magnitude of deaths was more evident in the first years (0–4) and late adolescence (15–19), the study suggests that age-specific approaches may impact the control of fatal outcomes caused by sickle cell disease in Brazil.
publishDate 2022
dc.date.none.fl_str_mv 2022-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102022000100254
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102022000100254
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.11606/s1518-8787.2022056003681
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
publisher.none.fl_str_mv Faculdade de Saúde Pública da Universidade de São Paulo
dc.source.none.fl_str_mv Revista de Saúde Pública v.56 2022
reponame:Revista de Saúde Pública
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Revista de Saúde Pública
collection Revista de Saúde Pública
repository.name.fl_str_mv Revista de Saúde Pública - Universidade de São Paulo (USP)
repository.mail.fl_str_mv revsp@org.usp.br||revsp1@usp.br
_version_ 1748936506945306624